---
figid: PMC6310611__nihms-1000667-f0002
figtitle: Metabolomics reveals the limitations for the in vivo application of GNF-351
  due to poor absorption and high metabolism
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6310611
filename: nihms-1000667-f0002.jpg
figlink: /pmc/articles/PMC6310611/figure/F2/
number: F2
caption: Metabolomics reveals the limitations for the in vivo application of GNF-351
  due to poor absorption and high metabolism. The metabolic pathway was determined
  using UPLC-ESI-QTOFMS-based metabolomics. Red color highlights the drug-metabolizing
  enzymes regulated by Ahr
papertitle: 'LC–MS‑based metabolomics: an update.'
reftext: Zhong‑Ze Fang, et al. Arch Toxicol. 2014 Aug;88(8):1491-1502.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8187551
figid_alias: PMC6310611__F2
figtype: Figure
redirect_from: /figures/PMC6310611__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6310611__nihms-1000667-f0002.html
  '@type': Dataset
  description: Metabolomics reveals the limitations for the in vivo application of
    GNF-351 due to poor absorption and high metabolism. The metabolic pathway was
    determined using UPLC-ESI-QTOFMS-based metabolomics. Red color highlights the
    drug-metabolizing enzymes regulated by Ahr
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AHR
  - CYP3A4
  - CYP1A1
  - CYP2D6
  - CYP2D7
  - TBXAS1
  - NM
  - F2
  - F3
  - F5
---
